We are live on ! Find out more
MC

Muhlenkamp & Co Portfolio holdings

AUM $380M
1-Year Est. Return 43.74%
This Fund
S&P 500
This Quarter Est. Return
+7.88%
1 Year Est. Return
+43.74%
3 Year Est. Return
+121.38%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$318M
AUM Growth
-$1.68M
Cap. Flow
-$19.1M
Cap. Flow %
-6.02%
Top 10 Hldgs %
48.4%
Holding
84
New
6
Increased
–
Reduced
37
Closed
9

Top Buys

1
CTSH icon
Cognizant
CTSH
+$6.48M

Top Sells

1
BFH icon
Bread Financial
BFH
+$11.4M
2
SLB icon
SLB Ltd
SLB
+$4.81M
3
NPSN
NASPERS LTD
NPSN
+$3.56M
4
SAVE
Spirit Airlines, Inc.
SAVE
+$3.28M
5
TEVA icon
Teva Pharmaceuticals
TEVA
+$2.38M

Sector Composition

1 Healthcare 26.52%
2 Technology 26.25%
3 Consumer Discretionary 9.48%
4 Financials 7.86%
5 Materials 6.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AAPL icon
1
Apple
AAPL
$4.89T
$22.7M 7.15%
589,604
-2,980
-0.5% -$116K
ON icon
2
ON Semiconductor
ON
$34.3B
$22.4M 7.05%
1,211,925
-26,395
-2% -$425K
GILD icon
3
Gilead Sciences
GILD
$169B
$18.2M 5.72%
224,147
-1,538
-0.7% -$118K
MSFT icon
4
Microsoft
MSFT
$2.98T
$17.2M 5.43%
231,413
-975
-0.4% -$71.2K
BFH icon
5
Bread Financial
BFH
$3.97B
$15.5M 4.87%
87,437
-61,221
-41% -$11.4M
HBI
6
DELISTED
Hanesbrands
HBI
$11.9M 3.75%
483,137
-14,629
-3% -$351K
RUSHA icon
7
Rush Enterprises Class A
RUSHA
$6.19B
$11.7M 3.67%
567,027
– –
UNH icon
8
UnitedHealth
UNH
$384B
$11.5M 3.62%
58,699
-325
-0.6% -$62.8K
CE icon
9
Celanese
CE
$5.02B
$11.4M 3.59%
109,335
-12,830
-11% -$1.26M
BMY icon
10
Bristol-Myers Squibb
BMY
$124B
$11.3M 3.56%
177,169
-805
-0.5% -$47K
MCK icon
11
McKesson
MCK
$98.5B
$10.9M 3.43%
70,956
-409
-0.6% -$63.8K
CELG
12
DELISTED
Celgene Corp
CELG
$10.4M 3.28%
71,455
-963
-1% -$131K
GLD icon
13
SPDR Gold Trust
GLD
$130B
$10M 3.16%
82,630
-1,970
-2% -$240K
MCHP icon
14
Microchip Technology
MCHP
$44.4B
$8.87M 2.79%
197,630
-1,710
-0.9% -$71.7K
FHI icon
15
Federated Hermes
FHI
$4.53B
$8.67M 2.73%
291,886
-7,050
-2% -$198K
LCI
16
DELISTED
Lannett Company, Inc.
LCI
$8.39M 2.64%
113,718
-7,797
-6% -$572K
CCJ icon
17
Cameco
CCJ
$38B
$8.37M 2.63%
865,258
-5,540
-0.6% -$55K
DD icon
18
DuPont de Nemours
DD
$18.1B
$8.09M 2.55%
46,160
-395
-0.8% -$65.9K
BIIB icon
19
Biogen
BIIB
$30.8B
$7.69M 2.42%
24,547
-998
-4% -$296K
CTSH icon
20
Cognizant
CTSH
$21.1B
$6.69M 2.11%
+92,220
New +$6.48M
DAL icon
21
Delta Air Lines
DAL
$57B
$6.28M 1.98%
130,145
-2,005
-2% -$99.9K
GMLP
22
DELISTED
Golar LNG Partners LP
GMLP
$5.89M 1.85%
253,435
-7,360
-3% -$157K
OLED icon
23
Universal Display
OLED
$3.73B
$5.47M 1.72%
42,435
– –
GME icon
24
GameStop
GME
$9.84B
$5.26M 1.66%
1,018,800
-7,276
-0.7% -$37.7K
ESRX
25
DELISTED
Express Scripts Holding Company
ESRX
$3.88M 1.22%
61,215
-764
-1% -$47.5K
1
2 3 4

Similar funds

AC
Attestor Capital Grand Cayman, Cayman Islands $380M AUM
MW
Marks Wealth Annapolis, Maryland $380M AUM 40.02% 1-Year Est. Return
EAM
Empirical Asset Management Wellesley, Massachusetts $379M AUM 24.52% 1-Year Est. Return
RWA
Rooted Wealth Advisors Bourbonnais, Illinois $379M AUM 13.75% 1-Year Est. Return
CSWG
Cardinal Strategic Wealth Guidance Louisville, Kentucky $379M AUM 19.59% 1-Year Est. Return
BP
BWM Planning The Woodlands, Texas $379M AUM 21.72% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
KFS
Kurt F. Somerville $379M AUM 19.42% 1-Year Est. Return

Muhlenkamp & Co's Q3 2017 Portfolio in Review

As of Q3 2017, Muhlenkamp & Co held 84 positions worth $318M, down 0.52% from $319M the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Muhlenkamp & Co withdrew a net $19.1M in Q3 2017, closing 9 positions and reducing 37 holdings. Its most notable exit was SLB Ltd, an estimated $4.81M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, up from 26% a quarter earlier, followed by Technology and Consumer Discretionary.

Against the trend, Muhlenkamp & Co opened a new position in Cognizant worth $6.69M.

  • Muhlenkamp & Co's largest Q3 2017 buy was Cognizant: 92,220 shares worth $6.69M.
  • Muhlenkamp & Co's biggest Q3 2017 reduction was Bread Financial, cutting an estimated $11.4M.
  • Muhlenkamp & Co fully exited SLB Ltd in Q3 2017, selling an estimated $4.81M.
  • Muhlenkamp & Co's ten largest holdings make up 48% of its $318M portfolio in Q3 2017.
  • Muhlenkamp & Co opened 6 new positions and closed 9 in Q3 2017.
  • Muhlenkamp & Co's portfolio value fell 0.52% quarter-over-quarter to $318M.

Based on Muhlenkamp & Co's 13F filing for Q3 2017, filed 13 Nov 2017.